CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Ana Feliu

OPENALEX: A5038334321↗ORCID: 0000-0002-1157-1525↗

Affiliations

Organizations

Instituto Cajalauthorship · ES

Public evidence

4 connected articles

Perspectives on Cannabis-Based Therapy of Multiple Sclerosis: A Mini-Review.2020 · Europe PMC Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy.2018 · Europe PMC Brain innate immunity in the regulation of neuroinflammation: therapeutic strategies by modulating CD200-CD200R interaction involve the cannabinoid system.2014 · Europe PMC A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis.2014 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 09/09/2026.

Ana Feliu - Medical Cannabis Research Engine